A Column Agglutination Test (CAT) card is a diagnostic tool used primarily in immunohematology to perform blood typing, antibody screening, and cross-matching. It employs a method similar to microcolumn gel cards, where agglutination (clumping) reactions are used to identify specific antigens or antibodies in blood samples.

The global Column Agglutination Test Cards market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Column Agglutination Test Cards Industry Forecast” looks at past sales and reviews total world Column Agglutination Test Cards sales in 2023, providing a comprehensive analysis by region and market sector of projected Column Agglutination Test Cards sales for 2024 through 2030. With Column Agglutination Test Cards sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Column Agglutination Test Cards industry.

This Insight Report provides a comprehensive analysis of the global Column Agglutination Test Cards landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Column Agglutination Test Cards portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Column Agglutination Test Cards market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Column Agglutination Test Cards and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Column Agglutination Test Cards.

The Gel Card Method is based on the principles of agglutination and hemagglutination. Agglutination is the clumping together of particles – in this case, red blood cells (RBCs). The RBCs will agglutinate when mixed with sera containing the corresponding antibodies. The degree of agglutination in the microtubes within the gel card is then used to determine the blood group.

This report presents a comprehensive overview, market shares, and growth opportunities of Column Agglutination Test Cards market by product type, application, key manufacturers and key regions and countries.

• Blood Grouping Forward and Reverse Test
• Cross Match Test
• Other

• Hospitals
• Research Centers
• Laboratory
• Others

This report also splits the market by region:

• United States
• Canada
• Mexico
• Brazil

• China
• Japan
• Korea
• Southeast Asia
• India
• Australia

• Germany
• France
• UK
• Italy
• Russia

• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Grifols
• Bio-Rad
• Ortho Clinical Diagnostics (QuidelOrtho)
• Turklab
• Tulip Diagnostics (PerkinElmer)
• Redcell Biotechnology
• Dia Pro Tıbbi Ürünler
• Aikang MedTech
• Tianjin Dexiang Biotech
• POLYRICHE BIOTECH
• Hubei Longtime Biological
• Singapore BioSciences

1. What is the 10-year outlook for the global Column Agglutination Test Cards market?
2. What factors are driving Column Agglutination Test Cards market growth, globally and by region?
3. Which technologies are poised for the fastest growth by market and region?
4. How do Column Agglutination Test Cards market opportunities vary by end market size?
5. How does Column Agglutination Test Cards break out by Type, by Application?